BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8844482)

  • 1. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.
    Tada H; Saitoh S; Nakagawa Y; Hirana H; Morimoto M; Shima T; Shimamoto K; Okanoue T; Kashima K
    J Gastroenterol; 1996 Aug; 31(4):582-4. PubMed ID: 8844482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of ischemic colitis associated with interferon treatment].
    Horigome H; Takezono Y; Fujino N; Uchida A; Murasaki G
    Nihon Shokakibyo Gakkai Zasshi; 1996 Mar; 93(3):181-4. PubMed ID: 8721113
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
    Veerabagu MP; Finkelstein SD; Rabinovitz M
    Dig Dis Sci; 1997 Jul; 42(7):1445-8. PubMed ID: 9246044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
    Leung Y; Urbanski SJ; Schindel L; Myers RP
    Can J Gastroenterol; 2006 Oct; 20(10):661-3. PubMed ID: 17066158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report.
    Liu Y; Chen H; Xu ZY
    Medicine (Baltimore); 2023 Apr; 102(14):e33378. PubMed ID: 37026950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
    Khan HA; Khawaja FI; Mahrous AR
    Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon-ribavirin-associated ischemic colitis.
    Punnam SR; Pothula VR; Gourineni N; Punnam A; Ranganathan V
    J Clin Gastroenterol; 2008 Mar; 42(3):323-5. PubMed ID: 18223489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic anemia provoked by recombinant alpha-interferon.
    Takase K; Nakano T; Hamada M; Shiraki K; Oohashi Y; Kihira T; Tameda Y
    J Gastroenterol; 1995 Dec; 30(6):795-7. PubMed ID: 8963402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid growth of hepatocellular carcinoma after or during interferon treatment of chronic hepatitis C: report of three cases.
    Onitsuka A; Yamada N; Yasuda H; Miyata T; Kachi T
    Surg Today; 1996; 26(2):126-30. PubMed ID: 8919284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C].
    Bacq Y; Sapey T; Gruel Y; Fimbel B; Degenne D; Barin F; Metman EH
    Gastroenterol Clin Biol; 1996; 20(3):303-6. PubMed ID: 8763070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
    Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interferon induced IBD-like acute colitis--two cases of patients with chronic active hepatitis].
    Yamamoto Y; Sakatani N; Yano S; Kou K; Ochi S; Yoshida Y; Fujimoto R; Ohno K; Sawai S
    Nihon Shokakibyo Gakkai Zasshi; 1995 Sep; 92(9):1293-6. PubMed ID: 7474487
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarcoidosis after interferon therapy for chronic active hepatitis C.
    Teragawa H; Hondo T; Takahashi K; Watanabe H; Ohe H; Hattori N; Watanabe Y; Amano H; Hino F; Ohbayashi M; Urushihara T; Yonehara S
    Intern Med; 1996 Jan; 35(1):19-23. PubMed ID: 8652926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of granulomatous hepatitis during treatment with interferon-alpha 2b.
    Propst A; Propst T; Dietze O; Kathrein H; Judmeier G; Vogel W
    Dig Dis Sci; 1995 Oct; 40(10):2117-8. PubMed ID: 7587776
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
    Shinagawa J; Inagaki Y; Suzuki M; Atsukawa K; Yonei Y; Tsukada N; Miyamoto K; Suzuki O; Kawamura Y; Kiryu Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):899-903. PubMed ID: 7783385
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough of interferon therapy.
    Scalori A; Ricci A; Bellati G; Colloredo G; Roffi L
    Am J Gastroenterol; 1996 Oct; 91(10):2249-50. PubMed ID: 8855768
    [No Abstract]   [Full Text] [Related]  

  • 20. A patient with acute hepatitis C and possible IFN toxicity.
    Licata A; Di Marco V; Craxì A
    Dig Liver Dis; 2003 May; 35(5):372-3. PubMed ID: 12846412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.